Renowned medical researcher Donald Abrams, MD (and the Positive Health Program of the UCSF Medical Service @ San Francisco General Hospital) is seeking a few more patients for a government-funded study that features patients who consume cannabis.*
Patients accepted into the research program will have travel to San Francisco covered and receive cash payments. This research program is part of a continuum of medical cannabis-related research performed by Dr. Abrams and his staff.
The goal’s study is to assess whether using vaporized marijuana affects the safety of prescribed opioids in patients treated for chronic pain.
*To Join This Study You Must:
–Have Ongoing Chronic Pain
–Be 18 or older
–Be on a stable twice-daily dose of sustained-release oxycodone (Oxycontin) for at least 2 weeks before enrollment
–Be willing to give up marijuana for a month prior to entering the study
–Not be a cigarette and/or cigar smoker, or be willing not to smoke for 2 weeks before starting the study
–Meet some additional criteria
If You Are Eligible You Will:
–Spend 5 days and nights in a clinical research center at San Francisco General Hospital
–Have blood tests and other measurements done
–Inhale vaporized marijuana three times a day
If you’re interested in participating in this important medical research, and qualify for the necessary research protocols, please directly contact 415-476-9554 (x315).
Absent these kinds of well constructed scientific research programs to better understand and determine the medical utility of cannabinoids and cannabis, the federal government will continuously oppose patient access to whole-smoked cannabis, therefore this kind of research takes on an even greater sense of concern and scope than just how a specific therapy interacts with patients.